Clinical Trial Details
| Trial ID: | L1388 |
| Source ID: | NCT01312441 |
| Associated Drug: | Ergocalciferol |
| Title: | Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Vitamin D Deficiency|Renal Failure Chronic Requiring Hemodialysis |
| Interventions: | DRUG: Ergocalciferol|DRUG: Placebo |
| Outcome Measures: | Primary: The sustainability of 25-hydroxy-vitamin D levels after 6 months of vitamin D replenishment with ergocalciferol, 12 months | |
| Sponsor/Collaborators: | Sponsor: Albany College of Pharmacy and Health Sciences | Collaborators: VA Office of Research and Development|Hortense & Louis Rubin Dialysis Center|Satellite Healthcare |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 20 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT |
| Start Date: | 2011-01 |
| Completion Date: | 2015-08 |
| Results First Posted: | |
| Last Update Posted: | 2016-01-14 |
| Locations: | Stratton VA Medical Center, Albany, New York, 12208, United States|Hortense and Louis Rubin Dialysis Center, Clifton Park, New York, 12065, United States|Hortense and Louis Rubin Dialysis Center, Saratoga Springs, New York, 12866, United States|Hortense and Louis Rubin Dialysis Center, Troy, New York, 12180, United States |
| URL: | https://clinicaltrials.gov/show/NCT01312441 |
